Debate: Resection for early hepatocellular carcinoma

Area of Science:

• Hepatology and Surgical Oncology
• Gastroenterology
• Transplant Surgery

Background:

• Management of early hepatocellular carcinoma (HCC) in cirrhosis patients meeting Milan criteria remains debated.
• Liver transplantation offers excellent survival but is limited by organ scarcity.
• Hepatic resection presents a viable alternative for selected patients.

Purpose of the Study:

• To evaluate the role and safety of hepatic resection for early HCC in patients with well-compensated cirrhosis.
• To compare hepatic resection with liver transplantation as therapeutic options.
• To emphasize personalized treatment strategies over dogma.

Main Methods:

• Review of existing literature on liver transplantation and hepatic resection for early HCC.
• Analysis of safety, survival rates, and recurrence data for both treatment modalities.
• Discussion of the complementary roles of resection and transplantation.

Main Results:

• Hepatic resection is safe for early HCC in well-compensated cirrhosis.
• Five-year survival rates for resection are approximately 50%.
• Resection aids in understanding tumor biology and offers a potentially curative option.

Conclusions:

• Hepatic resection is a valuable therapeutic option, not mutually exclusive with transplantation.
• Resection can be complementary to liver transplantation.
• Optimal management requires individualized assessment based on clinical status, not rigid adherence to one approach.